Sling-therapy in medical rehabilitation
InterCollegas. - Vol. 1, N1, 2014
PDF

How to Cite

Istomin, A., & Lutsenko, O. (2014). Sling-therapy in medical rehabilitation. Inter Collegas, 1(1), 73-78. https://doi.org/10.35339/ic.1.1.73-78

Abstract

SLING-THERAPY IN MEDICAL REHABILITATION Istomin A.G., Lutsenko O.V. Kharkiv national medical university, Kharkiv, Ukraine Abstract. This overview deals with new for Ukraine method of physical rehabilitation – sling therapy. The restoration of muscular-skeletal function is realized by physical excesses with or without special devices. But the limiting factor in many cases is severe pain that person should overcome while excesses. One of the peculiarities of the sling therapy is that the suspension by itself is an unstable support of the body. Such unstable support causes redistribution of muscular tone and activates the coordination of the movements thus contributing to the restoring the balance. Several places of support and using such elastic cords provide the painless performance of the exercise. Sling therapy can be used for diagnostic of «the weak link» in muscle-skeletal chain, correction the asymmetry of muscular tone, relief of pain while performing the exercise, and for improvement of the coordination of movements. Keywords: sling therapy, suspension therapy, physical rehabilitation, “weak links” testing, painless performance of the exercises. СЛИНГ - ТЕРАПІЯ У ФІЗИЧНОЇ РЕАБІЛІТАЦІЇ А.Г. Істомін, О.В. Луценко Харківський національний медичний університет, м. Харків, Україна Резюме. Цей огляд присвячений новому для України методу фізичної реабілітації - слінг терапії. Відновлення функції опорно -рухового апарату здійснюється за допомогою фізичних вправ з або без спеціальних пристроїв. Але обмежуючим фактором у багатьох випадках є сильний біль, який людина повинна долати під час фізичних вправ. Одна з особливостей слінг - терапії є те, що підвіска сама по собі є нестійкою підтримкою тіла. Така нестабільна підтримка викликає перерозподіл м'язового тонусу і активізує координацію руху, таким чином, сприяючи відновленню балансу. Кілька місць підтримки при використання таких еластичних шнурів забезпечує безболісне виконання вправ. Слінг - терапія може бути використана для діагностики «слабкої ланки» м'язово- скелетного ланцюга, корекції асиметрії м'язового тонусу, полегшення болю під час виконання вправ, а також для поліпшення координації рухів. Ключові слова: слінг-терапія, підвісна терапія, фізична реабілітація, тестування «слабої ланки», вправи без больових відчуттів. СЛИНГ-ТЕРАПИЯ В ФИЗИЧЕСКОЙ РЕАБИЛИТАЦИИ  А.Г. Истомин, О.В. Луценко Харьковский национальный медицинский университет, г. Харьков, Украина Резюме. Этот обзор посвящен новому для Украины методу физической реабилитации - слинг терапии. Восстановление функции опорно-двигательного аппарата осуществляется с помощью физических упражнений с или без специальных устройств. Но ограничивающим фактором во многих случаях является сильная боль, которую человек должен преодолевать во время физических упражнений. Одна из особенностей слинг-терапии является то, что подвеска сама по себе является неустойчивой поддержкой тела. Такая нестабильная поддержка вызывает перераспределение мышечного тонуса и активизирует координацию движения, таким образом, способствуя восстановлению баланса. Несколько мест поддержки при использования таких эластичных шнуров обеспечивает безболезненное выполнение упражнений. Слинг - терапия может быть использована для диагностики «слабого звена» в мышечно-скелетной цепи, коррекции асимметрии мышечного тонуса, облегчение боли во время выполнения упражнения, а также для улучшения координации движений. Ключевые слова: слинг-терапия, подвесная терапия, физическая реабилитация, тестирование «слабого звена», боль при выполнении упражнений.

https://doi.org/10.35339/ic.1.1.73-78
PDF

References

Kimura G. Hypertension and chronic kidney disease. J. Japan. Soc. Intern. Med. 2011; 100: 784-788

Ritz E. World Kidney Day Organising Committee. World Kidney Day: hypertension and chronic kidney disease. Lancet. 2009;.373: 1157-1158

Ragino Ju N, Chernjavskij A M, Polonskaja Ja V. Activity of inflammatory and destructive changes in the formation of unstable atherosclerotic plaque. Cardiology. 2007; 9: 62-66.

(Активность воспалительно-деструктивных изменений в процессе формирования нестабильной атеросклеротической бляшки / Ю.Н. Рагино [и др. ] // Кардиология – 2007. – № 9. – C. 62- 66.)

Bondar T N. L-argininum system, NO and immunity. Experimental and clinical medicine. 2009; 3; 4-8.

(Бондарь, Т.Н. Система L-аргинин, оксид азота и иммунитет / Т.Н. Бондарь// Експерименталь-на і клінічна медицина. – 2009. – № 3. – С. 4-8.)

Galjavich A S, Hamidullina A R, Galjavich R A. The influence of antihypertensive substances on some hymoral indexes of endothelial function. Cardiology 2009; 5: 30-33.

(Галявич, А.С. Влияние антигипертензивных средств на некоторые гуморальные показатели функции эндотелия/ А.С. Галявич, А.Р. Хамидуллина, Р.А. Галявич// Кардиология. – 2009. – № 5. – С. 30-33.)

Galjavich AS. The contemporary pharmacotherapy of patients with arterial hypertension and with high risk of cardio-vascular complications: the angiothensin converting enzyme inhibitors are in the focus. Medical council. 2012; 12: 10-17.

(Галявич, А. С. Cовременная фармакотерапия пациентов с артериальной гипертензией и высо-ким риском сердечно-сосудистых осложнений: в фокусе ингибиторы ангиотензинпревращающего фер-мента / А. С. Галявич // Медицинский совет. – 2012. – № 12. – С. 10-17.)

Sinjachenko O.V., Ignatenko G.A., Muhin I.V., Kosheleva E.N. The comparative efficacy of hypotensive and nephroprotective tricomponent therapy of chronic forms of glomerylonephritis. Ukrainian Journal of Nephrology and Dialysis. 2006; №1(8): 8-13.

(Cравнительная гипотензивная и нефропротекторная эффективность трехкомпонентной тера-пии при хронических формах гломерулонефрита / О.С. Синяченко [и др. ] // Український журнал нефро-логії та діалізу. – 2006. – № 1 (8). – С. 8-13.)

Malaj L.N., Miroshnichenko A.N., Sharykin B.V., Konurovskij V.V. To the 110 anniversary of rhenin discovery. Titans’ competition: ACE-inhibitors and sartans. Rational pharmacotherapy in cardiology. 2009; №4: 85-92.

(К 110-летию открытия ренина. Битва титанов:ингибиторы апф и сартаны / Л. Н. Малай [и др. ] // Рациональная фармакотерапия в кардиологии. – 2009. – № 4. – С 85-92.)

Smirnov A V, Petrishchev N N, Mnuskina M M, Panina I Iu, Rumiantsev A Sh, Vasina E Iu, et al. Endothelial dysfunction and apoptosis at early stage of chronic kidney disease. Ter. Arkh. 2012; 84(6): P.9-15.

Koval'ova O.M., Demidenko G.V., Gorbach T.V. The examination of endothelial function – assessment of vasoactive NO’s pool. (Methodical recommendations). Kiev, 2007: 12-16.

(Ковальова, О.М. Діагностикаендотеліальноїфункції – оцінкавазоактивногопулуоксидуазоту (методичнірекомендації) / О.М. Ковальова, Г.В. Демиденко, Т.В. Горбач. – Київ, 2007. – C. 12-16.)

Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, Tager M, Bode-Boger SM. Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging. Hypertension 2008;51:696 –703.

Nibieradze D.V., Oganov R.G. Metabolic and vascular effects of antihypertensive therapy. Moscow: Universum Pablishing, 2005.

(Нибиерадзе, Д.В. Метаболические и сосудистые эффекты антигипертензивной терапии / Д. В. Нибиерадзе, Р. Г. Органов. – Москва:Универсум Паблишинг, 2005. – 270 c.)

"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.

Copyright Agreement
1. This Agreement on the transfer of rights to use the work from the Co-authors to the publisher (hereinafter the Agreement) is concluded between all the Co-authors of the work, represented by the Corresponding Author, and Kharkiv National Medical University (hereinafter the University), represented by an authorized representative of the Editorial Board of scientific journals (hereinafter the Editorial Board).
2. This Agreement is an accession agreement within the meaning of clause 1 of Article 634 of the Civil Code of Ukraine: that is, a contract, "the terms of which are established by one of the parties in forms or other standard forms, which can be concluded only by joining the other party to the proposed contract as a whole. The other party cannot offer its terms of the contract." The party that established the terms of this contract is the University.
3. If there is more than one author, the authors choose the Corresponding Author, who communicates with the Editorial Board on his own behalf and on behalf of all Co-authors regarding the publication of a written work of a scientific nature (article or review, hereinafter referred to as the Work).
4. The contract begins from the moment of submission of the manuscript of the Work by the Corresponding Author to the Editorial Board, which confirms the following:
4.1. all Co-authors of the Work are familiar with and agree with its content, at all stages of reviewing and editing the manuscript and the existence of the published Work;
4.2. all Co-authors of the Work are familiar with and agree to the terms of this Agreement.
5. The published Work is in electronic form in public access on the websites of the University and any websites and electronic databases in which the Work is posted by the University and is available to readers under the terms of the "Creative Commons" license (Attribution NonCommercial Sharealike 4.0 International)" or more free licenses "Creative Commons 4.0".
6. The Corresponding Author transfers, and the University receives, the non-exclusive property right to use the Work by placing the latter on the University's websites for the entire term of copyright. The University participates in the creation of the final version of the Work by reviewing and editing the manuscript of the article or review provided to the Editorial Board by the Corresponding Author, translating the Work into any languages. For the participation of the University in the finalization of the Work, the Co-authors agree to pay the invoice issued to them by the University, if such payment is provided by the University. The size and procedure of such payment are not the subject of this contract.
7. The University has the right to reproduce the Work or its parts in electronic and printed forms, to make copies, permanent archival storage of the Work, distribution of the Work on the Internet, repositories, scientometric databases, commercial networks, including for monetary compensation from third parties.
8. The co-authors guarantee that the manuscript of the Work does not use works whose copyright belongs to third parties.
9. The authors of the Work guarantee that at the time of submission of the manuscript of the Work to the Editorial Board, the property rights to the Work belong only to them, neither in whole nor in part have they been transferred to anyone (not alienated), they are not the subject of a lien, litigation or claims by third parties.
10. The Work may not be posted on the University's website if it violates a person's right to the privacy of his personal and family life, harms public order and health.
11. The work may be withdrawn by the Editorial Board from the University websites, libraries and electronic databases where it was placed by the Editorial Board, in cases of detection of violations of the ethics of the authors and researchers, without any compensation for the losses of the Co-authors. At the time of submission of the manuscript to the Editorial Board and all stages of its editing and review, the manuscript must not have already been published or submitted to other editorial offices.
12. The right transferred under this Agreement extends to the territory of Ukraine and foreign countries.
13. The rights of Co-authors include the requirement to indicate their names on all copies of the Work or during any public use or public mention of the Work; the requirement to preserve the integrity of the Work; legal opposition to any distortion or other encroachment on the Work, which may harm the honor and reputation of the Co-authors.
14. Co-authors have the right to control their personal non-property rights by familiarizing themselves with the text (content) and form of the Work before its publication on the University's website, when transferring it to a printing company for reproduction or when using the Work in other ways.
15. The Co-authors, in addition to the property rights not transferred under this Agreement and taking into account the non-exclusive nature of the rights transferred under this Agreement, retain the property rights to finalize the Work and to use certain parts of the Work in other works created by the Co-authors.
16. The Co-authors are obliged to notify the Editorial Board of all errors in the Work, discovered by them independently after the publication of the Work, and to take all measures to eliminate such errors as soon as possible.
17. The University undertakes to indicate the names of the Co-authors on all copies of the Work during any public use of the Work. The list of Co-authors may be shortened according to the rules for the formation of bibliographic descriptions determined by the University or third parties.
18. The University undertakes not to violate the integrity of the Work, to agree with the Corresponding Author on all changes made to the Work during processing and editing.
19. In case of violation of their obligations under this Agreement, its parties bear the responsibility defined by this Agreement and the current legislation of Ukraine. All disputes under the Agreement are resolved through negotiations, and if the negotiations do not resolve the dispute – in the courts of the city of Kharkiv.
20. The parties are not responsible for the violation of their obligations under this Agreement, if it occurred through no fault of theirs. The party is considered innocent if it proves that it has taken all measures dependent on it for the proper fulfillment of the obligation.
21. The Co-authors are responsible for the truthfulness of the facts, quotes, references to legislative and regulatory acts, other official documentation, the scientific validity of the Work, all types of responsibility to third parties who have claimed their rights to the Work. The co-authors reimburse the University for all costs caused by claims of third parties for infringement of copyright and other rights to the Work, as well as additional material costs related to the elimination of identified defects.